Robert Cohen
Director
since August 2020
Robert Cohen served as Zomedica’s Chief Executive Officer first as the interim CEO from June 2020 until December 31, 2020 after which he was appointed as CEO from January 1, 2021 until November 1, 2021. Before his 20 years in the CEO position, he was a member of senior management at large multinationals, including St. Jude Medical, Inc., Sulzermedica, and Pfizer, Inc. He received his Bachelor of Arts from Bates College and a J.D. from the University of Maine School of Law.